Hancock Jaffe Laboratories Inc (HJLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HJLI | CSBR | PYPD | ||
| Company | Hancock Jaffe Laboratories Inc | Champions Oncolog | Polypid Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.71 | 6.49 | 4.60 | ||
| High | 10.75 | 6.49 | 4.70 | ||
| Low | 10.26 | 6.34 | 4.59 | ||
| Latest | 10.38 | 6.34 | 4.66 | ||
| Change | -0.21 | -0.16 | +0.05 | ||
| % Change | -1.98% | -2.46% | +0.97% | ||
| Volume | 221,800 | 8,800 | 34,000 | ||
| 20-Day Average Volume | 295,705 | 8,930 | 159,325 | ||
| Previous Close | 10.59 | 6.50 | 4.62 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 9.16 | 5.93 | 4.74 | ||
| 20-Day Raw Stochastic | 73.54% | 52.86% | 32.72% | ||
| 20-Day Relative Strength | 67.86 | 57.97 | 51.23 | ||
| Weighted Alpha | +9.05 | -15.86 | +40.66 | ||
| Today's Opinion | 88% Buy | 24% Sell | 80% Buy | ||
| Previous Opinion | 88% Buy | 8% Sell | 80% Buy | ||
| Last Month's Opinion | 40% Buy | 40% Sell | 32% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.34% since 09/23/21 | +12.41% since 06/08/26 | +0.97% since 06/08/26 | ||
| Low | 9.49 on 09/24/21 | 5.68 on 06/09/26 | 4.44 on 06/09/26 | ||
| High | 11.38 on 09/29/21 | 7.00 on 06/12/26 | 4.80 on 06/11/26 | ||
| 1-Month | |||||
| %Chg | +34.98% since 08/30/21 | +2.26% since 05/15/26 | +4.60% since 05/15/26 | ||
| Low | 7.60 on 09/07/21 | 5.60 on 06/08/26 | 4.40 on 06/08/26 | ||
| High | 11.38 on 09/29/21 | 7.00 on 06/12/26 | 5.21 on 06/02/26 | ||
| 3-Month | |||||
| %Chg | +51.09% since 06/30/21 | +3.93% since 03/13/26 | +11.34% since 03/13/26 | ||
| Low | 5.36 on 07/19/21 | 5.60 on 06/08/26 | 4.03 on 03/24/26 | ||
| High | 11.38 on 09/29/21 | 7.00 on 06/12/26 | 5.21 on 06/02/26 | ||
| 6-Month | |||||
| %Chg | +62.70% since 03/30/21 | -18.72% since 12/15/25 | +16.63% since 12/15/25 | ||
| Low | 4.99 on 05/13/21 | 5.50 on 03/13/26 | 3.89 on 12/19/25 | ||
| High | 11.38 on 09/29/21 | 7.79 on 12/16/25 | 5.21 on 06/02/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 90,146 | 90,266 | 88,163 | ||
| Shares Outstanding, K | 8,685 | 13,887 | 19,083 | ||
| Annual Sales | 0 | 56,940,000 | 0 | ||
| Annual Net Income | -9,140,000 | 4,700,000 | -34,170,000 | ||
| Last Quarter Sales | 0 | 16,560,000 | 0 | ||
| Last Quarter Net Income | -2,380,000 | -280,000 | -7,730,000 | ||
| 60-Month Beta | 1.51 | 0.41 | 1.42 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.02 on 03/12/26 | -0.35 on 05/13/26 | ||
| Earnings Date | 11/16/21 | 07/22/26 | 08/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||